Brief: Haemato FY EBITDA Up 74.8% At EUR 3.3 Mln
21/04/2021 09:48
April 21 (Reuters) - HAEMATO AG HAEk.DE :
* DGAP-NEWS: ACCORDING TO THE PRELIMINARY IFRS FINANCIAL
STATEMENTS FOR THE 2020 FINANCIAL YEAR, HAEMATO AG INCREASED ITS
REVENUE BY 20.5 % TO EUR 238.3 MILLION AND INCREASED EBITDA BY
74.8 % TO EUR 3.3 MILLION
* FY EBIT 1.6 MILLION EUR VERSUS -19,000 EUR LOSS YEAR AGO
* FY EBITDA ROSE 74.8 PERCENT TO 3.3 MILLION EUR
* FY REVENUE ROSE 20.5 PERCENT TO 238.3 MILLION EUR
* OUTLOOK 2021: AN ADDITIONAL SALES VOLUME OF AT LEAST EUR
25 TO
30 MILLION IS EXPECTED
* OUTLOOK 2021: ANTICIPATE SALES GROWTH TO EUR 260 TO 290
MILLION
* OUTLOOK 2021: IMPROVEMENT IN EBIT IN CURRENT FINANCIAL
YEAR TO
EUR 7 TO 9 MILLION
Source text for Eikon: ID:nEQ960BwCa
Further company coverage: HAEk.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Haemato AG
See all newsBrief: HAEMATO Raises FY EBIT Guidance to EUR 10-12 Million
Brief: Haemato Says Terminates Cooperation With Korean Manufacturer Huons Biopharma; To Discontinue Project For A Proprietary Botulinum Toxin
Brief: Haemato Q1 EBITDA At EUR 2.3 Mln
Brief: Haemato To Propose Dividend Of EUR 1.10 Per Share
Brief: Haemato Preliminary Consolidated FY EBIT Up At EUR 11.2 Mln